Asset Details
Do you wish to reserve the book?
Synthesis of conjugates of sesquiterpene lactones with 3,5-bis(arylidene)piperidin-4-ones as potential NF-κB modulators using phase transfer catalysis conditions
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Synthesis of conjugates of sesquiterpene lactones with 3,5-bis(arylidene)piperidin-4-ones as potential NF-κB modulators using phase transfer catalysis conditions
Do you wish to request the book?
Synthesis of conjugates of sesquiterpene lactones with 3,5-bis(arylidene)piperidin-4-ones as potential NF-κB modulators using phase transfer catalysis conditions
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Synthesis of conjugates of sesquiterpene lactones with 3,5-bis(arylidene)piperidin-4-ones as potential NF-κB modulators using phase transfer catalysis conditions
2024
Overview
A simple method for modifying sesquiterpene lactones with 3,5-bis(arylidene)piperi-din-4-ones using the phase-transfer catalytic aza-Michael addition in the MeCN—K
2
CO
3
system was developed. Molecular docking revealed that the synthesized conjugates of isoalantolactone, alantolactone, and dehydrocostus lactone with various bis(arylidene)-piperidones directly interact with the DNA binding site of the p50 subunit of nuclear factor κB, which may be indicative of their ability to induce apoptotic death of the tumor cells due to activation of the death receptor expression and, thereby, to exhibit an antitumor effect.
Publisher
Springer US,Springer Nature B.V
